Delirium News and Research

RSS

Delirium is a mental state in which a person is confused, disoriented, and not able to think or remember clearly. The person may also be agitated and have hallucinations, and extreme excitement.

‘Covid hit us over the head with a two-by-four’: Addressing ageism with urgency

Earlier this year, the World Health Organization announced a global campaign to combat ageism — discrimination against older adults that is pervasive and harmful but often unrecognized.

5 Nov 2021

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Offering patients a clinician team roster increases recognition and involvement

Offering patients a roster of clinicians on their care team increased recognition of each clinician's name and face during their treatment period, something patients also reported as highly significant to their care, according to research presented at American College of Cardiology Quality Summit Virtual, taking place Sept. 29 – Oct. 1, 2021.

29 Sep 2021

Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate

Patients with excited delirium who are combative, aggressive or agitated before being transported to the hospital or in an emergency department setting require immediate treatment for their safety and others.

29 Sep 2021

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

24 Sep 2021

Delirium is highly likely in patients hospitalized for severe COVID-19

More than a year into the COVID-19 pandemic, researchers are revealing the many devastating consequences that patients can face both during and after hospitalization.

21 Sep 2021

COVID-19 infections in Australian healthcare workers

A team of researchers performed state-wide SARS-CoV-2 genomic epidemiological investigations to recognize health care worker transmission dynamics and support optimizing healthcare system readiness for similar future outbreaks.

17 Sep 2021

New study receives $33 million PCORI funding to compare anesthetic medications

More than 50,000 surgical patients undergo general anesthesia every day in the United States, but clinicians and scientists lack evidence indicating which types of anesthesia drugs result in the best outcomes for patients.

9 Aug 2021

At urgent care, he got 5 stitches and a big surprise: A plastic surgeon’s bill for $1,040

It was a Sunday morning in late November when Bryan Keller hopped on a bike for a routine ride to pick up his groceries, cruising with ease in a relatively empty New York City.

2 Aug 2021

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

A new study published on the preprint server medRxiv* presents an analysis of the differences between recorded vaccination side effects vs. early COVID-19 symptoms. The researchers focused on four vaccines, namely, Pfizer-BioNTech (PB) mRNA (BNT162b2) vaccine, based on messenger ribonucleic acid encoding the viral spike protein; the Moderna mRNA (mRNA-1273) vaccine; the Oxford-AstraZeneca (O-AZ) adenovirus-vectored vaccine; and the Janssen adenovirus-vectored Ad26.COV2.S).

26 Jul 2021

Better healthcare processes can reduce the risk of delirium among elderly patients

Elderly patients with neurological conditions are significantly more likely to develop delirium shortly after they are hospitalized.

23 Jul 2021

Immune system dysfunction can alter the link between cannabis use and psychosis

The presence of pro-inflammatory cytokines in the blood can boost the effects of daily cannabis use and heighten the risk of developing psychosis in adulthood.

16 Jun 2021

An analysis links COVID-19 to brain microvascular injury and inflammation

The ongoing COVID-19 pandemic is caused by the severe acute respiratory syndrome-2 (SARS-CoV-2), an RNA virus that belongs to the family Coronaviridae. According to research, coronavirus disease 2019 (COVID-19) patients often suffer from neurological disorders like strokes, lost taste or smell, memory loss, confusion, and delirium.

13 Jun 2021

FDA grants accelerated approval for first-of-its-kind Alzheimer's treatment

Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.

7 Jun 2021